The fraction b 4-2: isolation, characterization and biological activities with reference to uremic polyneuropathy.
Man
N K
NK
Department of Nephrology, Necker Hospital, Paris, France.
Cueille
G
G
Faguer
P
P
Boudet
J
J
Pierrat
D
D
Zingraff
J
J
Sausse
A
A
Funck-Brentano
J L
JL
D000818:Animals; D002850:Chromatography, Gel; D004195:Disease Models, Animal; D006801:Humans; D008297:Male; D009498:Neurotoxins / Q000302:isolation & purification / Q000378:metabolism; D011115:Polyneuropathies / Q000209:etiology / Q000378:metabolism* / Q000628:therapy; D051381:Rats; D006435:Renal Dialysis; D014118:Toxins, Biological / Q000302:isolation & purification / Q000378:metabolism*; D014511:Uremia / Q000150:complications / Q000378:metabolism* / Q000628:therapy
D009498:Neurotoxins; D014118:Toxins, Biological; C026865:uremia middle molecule toxins